Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Parkinson's Disease

  Free Subscription


18.03.2019

1 J Neurochem
1 J Neurol Neurosurg Psychiatry
4 Mov Disord
2 Nat Rev Neurol
1 Neurol Clin Pract
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    J Neurochem

  1. FANG X, Tian P, Zhao X, Jiang C, et al
    Neuroprotective effects of an engineered commensal bacterium in the MPTP Parkinson disease mouse model via producing GLP-1.
    J Neurochem. 2019 Mar 9. doi: 10.1111/jnc.14694.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  2. JABBARI E, Woodside J, Guo T, Magdalinou NK, et al
    Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
    J Neurol Neurosurg Psychiatry. 2019 Mar 13. pii: jnnp-2018-320151.
    PubMed     Text format     Abstract available


    Mov Disord

  3. MAGHZI H, Hogg EJ, Tan E, Pagano G, et al
    Adrenoceptor agonists and antagonists and risk of Parkinson's disease.
    Mov Disord. 2019;34:442.
    PubMed     Text format    

  4. DE HEMPTINNE C, Wang DD, Miocinovic S, Chen W, et al
    Pallidal thermolesion unleashes gamma oscillations in the motor cortex in Parkinson's disease.
    Mov Disord. 2019 Mar 13. doi: 10.1002/mds.27658.
    PubMed     Text format     Abstract available

  5. MONDAL B, Choudhury S, Simon B, Baker MR, et al
    Noninvasive vagus nerve stimulation improves gait and reduces freezing of gait in Parkinson's disease.
    Mov Disord. 2019 Mar 14. doi: 10.1002/mds.27662.
    PubMed     Text format    

  6. GUO Y, Xu W, Liu FT, Li JQ, et al
    Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta-analysis of prospective cohort studies.
    Mov Disord. 2019 Mar 14. doi: 10.1002/mds.27665.
    PubMed     Text format     Abstract available


    Nat Rev Neurol

  7. WOOD H
    Naturally occurring antibodies target Parkinson disease pathology.
    Nat Rev Neurol. 2019 Mar 11. pii: 10.1038/s41582-019-0167.
    PubMed     Text format    

  8. ELKOUZI A, Vedam-Mai V, Eisinger RS, Okun MS, et al
    Emerging therapies in Parkinson disease - repurposed drugs and new approaches.
    Nat Rev Neurol. 2019 Mar 12. pii: 10.1038/s41582-019-0155.
    PubMed     Text format     Abstract available


    Neurol Clin Pract

  9. KATAOKA H, Sugie K
    Recent advancements in lateral trunk flexion in Parkinson disease.
    Neurol Clin Pract. 2019;9:74-82.
    PubMed     Text format     Abstract available


    PLoS One

  10. RUI Z, Qingling C, Xinyue Z, Xin Z, et al
    The related factors of sleep benefit in Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0212951.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  11. SHEN HH
    Core Concept: Can deep brain stimulation find success beyond Parkinson's disease?
    Proc Natl Acad Sci U S A. 2019;116:4764-4766.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: